Ping He
About Ping He
Ping He is an Associate Director of Biostatistics with extensive experience in global drug development and clinical trials across various medical fields. He has previously held positions at UMass Medical School and TIMI Study Group, and currently works at Travere Therapeutics.
Work at Travere Therapeutics
Ping He serves as the Associate Director of Biostatistics at Travere Therapeutics since 2020. In this role, he collaborates with cross-functional teams and manages Contract Research Organizations (CROs) on global drug development clinical trials. His work focuses on areas such as rare diseases, metabolism, endocrinology, and gastrointestinal disorders. He utilizes his expertise in biostatistics to support the design and analysis of clinical trials, ensuring the integrity and validity of the data collected.
Previous Experience at UMass Medical School
Prior to his role at Travere Therapeutics, Ping He worked at UMass Medical School as a Biostatistician II from 2005 to 2014. During his nine years in Worcester, Massachusetts, he developed algorithms for large ongoing global observational registries, specifically in the fields of immunology and rheumatology. His contributions helped advance research methodologies and improve data analysis in these medical areas.
Experience at TIMI Study Group
Ping He was employed as the Lead Biostatistician at the TIMI Study Group from 2014 to 2017. In this position, he was responsible for leading biostatistical efforts in various clinical studies. His work contributed to the design and analysis of clinical trials, enhancing the understanding of cardiovascular diseases and treatment outcomes.
Education and Expertise
Ping He earned a Master of Science (MS) degree from the University of Nebraska-Lincoln, where he studied double majors in Statistics and Survey Research & Methodology from 2003 to 2005. His educational background provides a strong foundation in statistical methods and research design, which he applies in his professional roles in biostatistics and clinical trial management.
Achievements in Drug Development
Throughout his career, Ping He has led Phase III-IV global drug development clinical trials in various therapeutic areas, including cardiovascular health, diabetes, and osteoporotic bone fractures. His leadership in these trials has contributed to advancements in treatment options and improved patient outcomes in these critical health areas.